Abstract
Studies of HIV-related symptom and treatment side effect prevalence often fail to distinguish individual causal attributions between the two types of problems. However, an understanding of causal appraisals is critical to clarifying and intervening on coping in the context of HIV symptoms and treatment side effects. The objectives of this study are (1) to present causal attributions of symptoms reported by HIV+ adults taking combination therapy and (2) to describe the differential impact on health-related quality of life. In a cross-sectional interview study, a convenience sample of 109 HIV-positive adults taking highly active antiretroviral therapy (HAART) were interviewed using a combination of self- and interviewer-administered measures of quality of life, physical problem checklists, and side effect and HIV-related symptom attribution assessments. The most prevalent physical problems were fatigue, stiff/painful joints, aching muscles, diarrhea, feelings of depression, and neuropathy. Those most commonly labeled as side effects of HAART included upset stomach, nausea/vomiting, constipation, and changes in taste. Most commonly cited as symptoms related to HIV disease were tender lymph nodes, night sweats, weight loss, fever, and loss of strength. Impact of side effects, symptoms, and both were associated with impaired physical and social functioning. Disease-related symptoms, but not side effects, were related to perceptions of general health. Results suggest that HIV-positive persons taking HAART make distinctions between symptoms of disease and side effects of treatment. Perceived disease-related symptoms and side effects have significant and unique associations with quality of life. Findings have implications for symptom and side effects management, provider relations, and future research.
Similar content being viewed by others
References
Ammassari, A., Murri, R., Pezzotti, P., Trotta, M., Ravisio, L., and DeLonis, P. (2001). Self reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28, 445-449.
Anderson, B., and Lutgendorf, S. (2000). Quality of life as an outcome measure in gynecologic malignancies. Current Opinion in Obstetrics and Gynecology, 12, 21-26.
Baker, G. A., Hesdon, B., and Marson, A. G. (2000). Quality-of-life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: A systematic review of methodology and reporting standards. Epilepsia, 41, 1357-1363.
Baker, D. W., Shapiro, M. F., Schur, C. L., and Freeman, H. (1998). A revised measure of symptom-specific health care use. Social Science and Medicine, 47, 1601-1609.
Centers for Disease Control and Prevention. (2000a). HIV/AIDS surveillance–General epidemiology. Retrieved 10 September 2001 from http://www.cdc.gov/hiv/graphics/images/l178/l178-1.htm.
Centers for Disease Control and Prevention. (2000b). Persons reported to be living with HIV infection and with AIDS, by state and age group, reported through December 2000. Retrieved 10 September 2001 from http://www.cdc.gov/hiv/stats/hasr1202/table1.htm.
Chesney, M. (1999). The challenge of adherence. Beta, 12, 10-13.
Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipa, G., and Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13(Supplement A), S271-S278.
Corcoran, W. E., and Durham, C. F. (2000). Quality of life as an outcome-based evaluation of coronary artery bypass graft critical paths using the SF-36. Quality Management in Health Care, 8, 72-81.
Fontaine, A., Larue, F., and Lassaunière, J. M. (1999). Physicians' recognition of the symptoms experienced by HIV patients: How reliable? Journal of Pain and Symptom Management, 18, 263-270.
Foster, J. H., Peters, T. J., and Marshall, E. J. (2000). Quality of life measures and outcome in alcohol-dependent men and women. Alcohol, 22, 45-52.
Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., and Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23, 386-395.
Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., Powell-Cope, G. M., Inouye, J., Henry, S. B., Nicholas, P. K., and Portillo, C. J. (1999a). Predictors of self-reported adherence in persons living with HIV disease. Aids Patient Care and StDs, 13, 185-197.
Holzemer, W. L., Henry, S. B., Nokes, K. M., Corless, I. B., Brown, M. A., Powell-Cope, G. M., Turner, J. G., and Inouye, J. (1999). Validation of the Sign and Symptom Check-List for Persons with HIV Disease (SSC-HIV). Journal of Advanced Nursing, 30, 1041-1049.
Justice, A. C., Chang, C. H., Rabeneck, L., and Zackin, R. (2001). Clinical importance of provider-reported HIV symptoms compared with patient-report. Medical Care, 39, 397-408.
Justice, A. C., Rabeneck, L., Hays, R. D., Wu, A. W., and Bozzette, S. A. (1999). Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. Journal of Acquired Immune Deficiency Syndromes, 21, 126-133.
Keller, S. D., Majkut, T. C., Kosinski, M., and Ware, J. E., Jr. (1999). Monitoring health outcomes among patients with arthritis using the SF-36 Health Survey: Overview. Medical Care, 37, MS1-9.
Koloski, N. A., Talley, N. J., and Boyce, P. M. (2001). Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: A critical review of the literature on symptom and psychosocial factors. American Journal of Gastroenterology, 96, 1340-1349.
Lazarus, R. S., and Folkman, S. (1984). Stress, appraisal, and coping. New York: Springer.
Leventhal, H., Diefenbach, M., and Leventhal, E. A. (1992). Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cognitive Therapy and Research, 16, 143-163.
Leventhal, H., Meyer, D., and Nerenz, D. (1980). The commonsense representations of illness danger. In S. Rachman (Ed.), Contributions to Medical Psychology Vol. 2, pp. 17-30). New York: Pergamon Press.
Leventhal, H., Nerenz, D. R., and Steele, D. J. (1984). Illness representations and coping with health threats. In A. Baum, S. E. Taylor, and J. E. Singer (Eds.), Handbook of psychology and health (Vol. 4, pp. 219-252). Hilsdale, NJ: Erlbaum.
Mathews, W. C., McCutchan, J. A., Asch, S., Turner, B. J., Gifford, A. L., Kuromiya, K., Brown, J., Shapiro, M. F., and Bozzette, S. A. (2000). National estimates of HIV-related symptom prevalence from the HIV Cost and Services Utilization Study. Med Care, 38, 750-762.
McHorney, C. A., Ware, J. E., Lu, J. F. R., and Sherbourne, C. D. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care, 32, 40-66.
McHorney, C. A., Ware, J. E., and Raczek, A. E. (1993). The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31, 247-263.
Mohr, D. C., Likosky, W., Boudewyn, A. C., Marietta, P., Dwyer, P., Van der Wende, J., and Goodkin, D. E. (1998). Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a. Multiple Sclerosis, 4, 487-489.
Nezu, A. M., Nezu, C. M., Friedman, S. H., Faddis, S., and Houts, P. S. (1998). Helping cancer patients cope: A problem-solving approach. Washington, DC: American Psychological Association.
Nezu, A. M., Nezu, C. M., and Perri, M. G. (1989). Problem-solving therapy for depression: Theory, research, and clinical guidelines: New York: Wiley.
Nezu, C. M., Nezu, A. M., and Houts, P. S. (1993). Multiple applications of problem-solving principles in clinical practice. In H. R. E. Kevin, T. Kuehlwein (Ed.), Cognitive therapies in action: Evolving innovative practice (pp. 353-378): Jossey-Bass, San Francisco.
Roca, B., Gómez, C. J., and Arnedo, A. (1999). Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: Adherence, side effects and efficacy. Journal of Infection, 39, 141-145.
Roca, B., Gómez, C. J., and Arnedo, A. (2000). Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients. Journal of Infection, 41, 50-54.
Salander, P., Bergenheim, A. T., Hamberg, K., and Henriksson, R. (1999). Pathways from symptoms to medical care: A descriptive study of symptom development and obstacles to early diagnosis in brain tumour patients. Family Practice, 16, 143-148.
Siegel, K., Dean, L., and Schrimshaw, E. W. (1999a). Symptom ambiguity among late-middle-aged and older adults with HIV. Research on Aging, 21, 595-618.
Siegel, K., Schrimshaw, E. W., and Dean, L. (1999b). Symptom interpretation and medication adherence among late middle-age and older HIV-infected adults. Journal of Health Psychology, 4, 247-257.
Stevens, J. (1996). Applied multivariate statistics for the social sciences (3rd ed.). Hillsdale, NJ: Erlbaum.
Tabachnick, B. G., and Fidell, L. S. (2001). Using multivariate statistics (4th ed ed.). Boston: Allyn and Bacon.
Touw, C. R., Hakkaart-Van Roijen, L., Verboom, P., Paul, C., Rutten, F. F., and Finlay, A. Y. (2001). Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. British Journal of Dermatology, 144, 967-972.
Vogl, D., Rosenfeld, B., Breitbart, W., Thaler, H., Passik, S., McDonald, M., and Portenoy, R. K. (1999). Symptom prevalence, characteristics, and distress in AIDS outpatients. Journal of Pain and Symptom Management, 18, 253-262.
Ware, J. E., Jr. (1999). SF-36 Health Survey. In E. Mark E. Maruish (Ed.), The use of psychological testing for treatment planning and outcomes assessment (2nd ed., pp. 1227-1246): Mahwah, NJ: Erlbaum.
Ware, J. E., Jr., and Gandek, B. (1998). Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. Journal of Clinical Epidemiology, 51, 903-912.
Ware, J. E., Gandek, B., and the IQOLA Project Group. (1994). The SF-36 Health Survey: Development and use in mental health research and the IQOLA Project. International Journal of Mental Health, 23, 49-73.
Weinman, J., Petrie, K. J., Moss-Morris, R., and Horne, R. (1996). The Illness Perception Questionnaire: A new method for assessing the cognitive representation of illness. Psychology and Health, 11, 431-445.
Whalen, G. F., and Ferrans, C. E. (2001). Quality of life as an outcome in clinical trials and cancer care: A primer for surgeons. Journal of Surgical Oncology, 77, 270-276.
Wilson, I. B., and Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273, 59-65.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnson, M.O., Stallworth, T. & Neilands, T.B. The Drugs or the Disease? Causal Attributions of Symptoms Held by HIV-Positive Adults on HAART. AIDS Behav 7, 109–117 (2003). https://doi.org/10.1023/A:1023938023005
Issue Date:
DOI: https://doi.org/10.1023/A:1023938023005